DURHAM, N.C.--(BUSINESS WIRE)--Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the second quarter of 2009 were $29.1 million, down 24 percent from $38.3 million in the second quarter of 2008, and up 5 percent from $27.8 million in the first quarter of 2009. Net sales of FUZEON in the U.S. and Canada for the second quarter of 2009 were $9.7 million, down 39 percent from $16.1 million in the second quarter of 2008, and down 2 percent from $10.0 million in the first quarter of 2009. Net sales of FUZEON outside the U.S. and Canada for the second quarter of 2009 were $19.4 million, down 13 percent from $22.2 million in the second quarter of 2008, and up 9 percent from $17.8 million in the first quarter of 2009. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd, ("Roche"), Trimeris' collaborative partner.
